Cancers that directly damage bone marrow cause low neutrophils

Low neutrophils — a condition called neutropenia — happens when cancer either grows in the bone marrow itself or when cancer treatment destroys the cells that make neutrophils. The cancers most likely to cause this are blood cancers: leukemia, lymphoma, and multiple myeloma. These cancers originate in or spread to bone marrow, crowding out the healthy cells that produce white blood cells. Solid tumors (lung, breast, colon) rarely cause neutropenia on their own, but their treatment often does.

When cancer occupies bone marrow space, it leaves less room for neutrophil-producing cells to work. Your body cannot make enough neutrophils to keep up with normal demand, and your count drops. This matters because neutrophils are your first line of defense against bacterial and fungal infections. A low count means your immune system has fewer soldiers on patrol, which is why people with neutropenia face higher infection risk even from germs that would not normally cause illness.

Key Takeaways

  • Blood cancers — leukemia, lymphoma, and multiple myeloma — directly damage bone marrow and are the most common cancer cause of low neutrophils.
  • Solid tumors usually do not lower neutrophils by themselves, but chemotherapy and radiation used to treat any cancer often do.
  • A neutrophil count below 1,500 cells per microliter is considered low; below 500 is severe and carries high infection risk.
  • Neutropenia from cancer treatment is usually temporary and recovers as bone marrow heals between treatment cycles.
  • Your oncology team monitors your neutrophil count with blood tests before and during treatment to adjust your care plan.

Leukemia and neutropenia: why the connection is direct

Leukemia is cancer of white blood cells themselves. In acute leukemias (acute myeloid leukemia and acute lymphoblastic leukemia), abnormal blast cells multiply so rapidly that they crowd out normal neutrophil-producing cells in the bone marrow. Even though the body is making white blood cells, they are the wrong kind — cancerous cells that do not function as neutrophils and do not protect against infection.

Chronic leukemias (chronic myeloid leukemia and chronic lymphocytic leukemia) develop more slowly, but they still occupy marrow space and interfere with normal neutrophil production. The result is the same: a low count of functional neutrophils despite high numbers of abnormal cells. This is why people with leukemia often have both neutropenia and a paradoxically high white blood cell count — the cells are there, but most are useless.

Lymphoma, multiple myeloma, and bone marrow involvement

Lymphoma (both Hodgkin and non-Hodgkin) can spread to bone marrow, where it takes up space and prevents normal blood cell production. Not all lymphomas involve the marrow — some stay in lymph nodes — but when they do, neutropenia follows. The degree of marrow involvement determines how low your neutrophil count drops.

Multiple myeloma is cancer of plasma cells in bone marrow. As myeloma cells multiply, they displace the cells responsible for making all blood cells, including neutrophils. Myeloma patients often have low neutrophils along with low red blood cells and platelets, a pattern called pancytopenia (low counts across all three cell lines). This makes infection risk and bleeding risk both significant concerns during myeloma treatment.

How cancer treatment causes neutropenia even in solid tumors

Chemotherapy drugs kill fast-dividing cells — which includes both cancer cells and the bone marrow cells that produce neutrophils. Radiation therapy to the chest, abdomen, or pelvis can damage bone marrow directly. The result is that people treated for solid tumors (breast, lung, colon, ovarian) often develop neutropenia during or shortly after treatment, even though their cancer did not start in the marrow.

This treatment-related neutropenia is usually temporary. Bone marrow recovers between chemotherapy cycles, and neutrophil counts rebound. However, if treatment is intensive or repeated, recovery may be incomplete, and counts may stay low throughout the treatment course. Your oncology team expects this and plans around it, sometimes delaying the next treatment cycle to allow marrow recovery or using medications like G-CSF (granulocyte colony-stimulating factor) to speed neutrophil production.

Neutrophil counts: what the numbers mean

A normal neutrophil count is 2,500 to 7,500 cells per microliter of blood. Counts between 1,000 and 1,500 are considered low but usually do not require major precautions. Counts between 500 and 1,000 carry moderate infection risk. Counts below 500 are severe neutropenia, and infection risk becomes very high — your care team may recommend isolation, prophylactic antibiotics, or hospitalization depending on other factors.

Your oncologist checks your neutrophil count with a complete blood count (CBC) before each treatment and sometimes between treatments. If your count is too low, your doctor may delay treatment, reduce the dose, or add growth factor medications. This is not a setback — it is standard safety management. Pushing forward with treatment when neutrophils are critically low increases the risk of serious infection that could interrupt your entire cancer treatment plan.

Managing infection risk when neutrophils are low

When your neutrophil count is low, your care team will give you specific instructions. These usually include washing hands frequently, avoiding crowds and people who are sick, not eating raw or undercooked foods (which can harbor bacteria), and reporting fever or signs of infection immediately. Fever in a neutropenic person is treated as a medical emergency because infection can progress rapidly without enough immune cells to fight it.

Some people receive prophylactic antibiotics or antifungal medications to prevent infection while neutrophils are low. Others receive G-CSF injections to stimulate bone marrow to produce neutrophils faster. These are standard tools in cancer care, and your oncology team will decide which approach fits your situation based on your cancer type, treatment plan, and how low your counts drop.

Recovery of neutrophil counts after cancer treatment ends

For most people, neutrophil counts recover fully once cancer treatment ends and bone marrow has time to heal. Recovery usually takes weeks to a few months, depending on how intensive the treatment was. Your doctor will continue monitoring with blood tests during this period to confirm recovery is happening.

Some people who received very high-dose chemotherapy or stem cell transplants may have a longer recovery period or, rarely, permanent damage to bone marrow. This is discussed before treatment begins, and your oncology team will explain what recovery timeline to expect for your specific plan. Knowing what to watch for and when counts should improve helps you recognize whether recovery is on track.

Frequently Asked Questions

Can low neutrophils from cancer be reversed?

Yes, in most cases. If neutropenia is caused by chemotherapy or radiation, counts usually recover once treatment ends and bone marrow heals. If it is caused by blood cancer in the marrow itself, neutrophil counts may improve once the cancer goes into remission and marrow function is restored. Your oncologist will explain what recovery looks like for your situation.

Is neutropenia from cancer treatment permanent?

Rarely. Most people's bone marrow recovers fully within weeks to months after treatment ends. Very high-dose chemotherapy or stem cell transplants carry a small risk of lasting marrow damage, but this is discussed before treatment begins. Your doctor monitors recovery with blood tests to confirm counts are returning to normal.

What should I do if I have fever and low neutrophils?

Contact your oncology team or go to the emergency room immediately. Fever in a neutropenic person is treated as urgent because infection can worsen quickly without enough white blood cells to fight it. Do not wait to see if the fever goes away on its own. Bring a list of your medications and your most recent blood count results.

Can I still receive cancer treatment if my neutrophils are low?

It depends on how low they are and what your treatment plan requires. Your oncologist may delay treatment to allow recovery, reduce the dose, or add growth factor medications to boost production. Treatment decisions balance the need to fight cancer against the risk of serious infection. Your care team will explain the reasoning behind any changes to your schedule.

Do all cancer patients develop low neutrophils?

No. People with blood cancers often have low neutrophils because the cancer itself damages bone marrow. People treated for solid tumors frequently develop neutropenia during chemotherapy, but the degree varies. Some people have only mild drops; others have severe neutropenia. Your individual risk depends on your cancer type, the specific drugs used, and how your bone marrow responds.